Array Biopharma, a provider of drug lead generation and optimization chemistry services to pharmaceutical and biotech firms for small-molecule drug discovery, cut the range for its 6 million share offering, which is scheduled to price Thursday for trading Friday, from $9-$11 to $8-$9. Lehman Brothers is the lead underwriter for this deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
